R. Kenneth (Ken) Boehner advises clients in mergers and acquisitions, financings, and joint ventures, with a particular focus on transactional matters where the key assets are intellectual property/technology. Most of his work involves a cross-border or international element. Ken has undertaken work for clients in the life sciences, medical devices, TMT (technology, media, and telecommunications), manufacturing, fashion/luxury goods, and consumer products sectors.
He has particular experience assisting U.S.-based companies with their transactional matters in EMEA and Asia, using more than 15 years of international experience to translate the legal and cultural norms of these markets into a familiar context. In addition, Ken has worked extensively with the private equity and venture capital communities to develop strategies for the creation and release of value from intellectual property assets.
Prior to joining Jones Day in 2013, Ken lived and practiced for nearly 20 years in Brussels and London. While in Brussels, he served as European “outside” general counsel to a publicly traded telecommunications company, providing legal support to senior management as the company organized, operated, and ultimately disposed of significant investments in a number of mobile telecommunications enterprises in Europe and the Middle East.
Following this period in Brussels, Ken spent almost 15 years in London, assisting clients with a variety of international transactional matters. During this period, he served as European managing partner of an AmLaw 100 firm, responsible for day-to-day management, strategic planning, and client service. This management role provided Ken with first-hand experience managing a large, international business.
- University of Notre Dame (J.D. 1993;
- B.A. in Economics magna cum laude 1990)
- New York and North Carolina;
- Solicitor of the Senior Courts of England and Wales
- Adecco Group acquires General Assembly Space, Inc. for $412.5 million
- Adecco Group acquires Vettery
- Smith & Nephew acquires Rotation Medical Inc. for up to $210 million
- Randstad acquires Monster for $429 million
- Axiall acquired by Westlake Chemical for $33 per share in all-cash transaction with $3.8 billion enterprise value
Rate : $$$$